Mechanical prevention of post-ERCP pancreatitis by pancreatic stents: Results, techniques, and indications

Journal of the Pancreas

Volumn 4, Issue 1, 2003, Pages 58-67

  Tarnasky, Paul R ^a  

^a Digestive Health Associates of Texas   (United States)

Author keywords

Acute disease; Cholangiopancreatography, endoscopic retrograde; Drainage; Endoscopy; Pancreas; Pancreatitis, acute necrotizing; Primary prevention; Sphincterotomy, endoscopic; Stents

Indexed keywords

ACUTE PANCREATITIS; ARTICLE; CANNULATION; CLINICAL TRIAL; COMMON BILE DUCT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SURGERY; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; ODDI SPHINCTER; PATHOGENESIS; RANDOMIZED CONTROLLED TRIAL; STENT; SURGICAL TECHNIQUE; TREATMENT INDICATION; VATER PAPILLA STENOSIS; VATER PAPILLOTOMY; ANIMAL; DRUG CONTRAINDICATION; IMPLANTATION; METHODOLOGY; PANCREATITIS; REVIEW; TREATMENT OUTCOME;

ANIMALS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; HUMANS; PANCREATITIS; PROSTHESIS IMPLANTATION; STENTS; TREATMENT OUTCOME;

EID: 0037264764     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Chen YK, Foliente RL, Santoro MJ, Walter MH, Colleen MJ. Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol 1994; 89:327-33. [AN 94168165]
2. Johnson GK, Geenen JE, Bedford RA, Johanson J, Cass O, Sherman S, et al. A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Gastrointest Endosc 1995; 42:312-6. [AN 96121321]
3. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335:909-18. [AN 96365275]
4. Deviere J, Le Moine O, van Laethem JL, Eisendrath P, Ghilain A, Severs N, Cohard M. Interleukin-10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001; 120:498-505. [AN 21100083]
5. Manolakopoulos S, Avgerinos A, Vlachogiannakos J, Armonis A, Viazis N, Papadimitriou N, et al. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial. Gastrointest Endosc 2002; 55:470-5. [AN 21920674]
6. Andriulli A, Clemente R, Solmi L, Terruzzi V, Suriani R, Sigillito A, et al. Gabexate or somatostatin administration before ERCP in patients at high-risk for post-ERCP pancreatitis: a multicenter, placebocontrolled, randomized clinical trial. Gastrointest Endosc 2002; 56:488-95. [AN 22233811]
7. Vandervoort J, Soetikno RM, Tham TC, Wong RC, Ferrari AP Jr, Montes H, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002; 56:652-6. [AN 22283811]
8. Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001; 96:417-23. [AN 21122345]
9. Tarnasky P, Cunningham J, Cotton P, Hoffman B, Palesch Y, Freeman J, et al. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy 1997; 29:252-7. [AN 97399400]
10. Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998; 115:1518-24. [AN 99055594]
11. Meyerson SM, Geenen JE, Johnson GK, Catalano MF, Gennen DJ, Schmalz MJ, et al. Pancreatic duct stenting decreases the incidence of post-ERCP pancreatitis: a prospective randomized study. Gastroenterology 1998; 114:G1967.
12. Smithline A, Silverman W, Rogers D, Nisi R, Wiersema M, Jamidar P, et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 1993; 39:652-7. [AN 94040541]
13. Fogel EL, Eversman D, Jamidar P, Sherman S, Lehman GA. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 2002; 34:280-5. [AN 21929640]
14. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001; 54:425-34. [AN 21460528]
15. Akashi R, Kiyozumi T, Tanaka T, Sakurai K, Oda Y, Sagara K. Mechanism of pancreatitis caused by ERCP. Gastrointest Endosc 2002; 55:50-4. [AN 21629113]
16. Sherman S, Earle D, Bucksot L, Esber E, Pezzi J, Gottlieb K, et al. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-induced pancreatitis?: randomized prospective study. Am J Gastroenterol 1995; 90:1614.
17. Kasmin FE, Cohen D, Batra S, Cohen SA, Siegel JH. Needle-knife sphincterotomy in a tertiary referral center: efficacy and complications. Gastrointest Endosc 1996; 44:48-53. [AN 96433736]
18. Binmoeller KF, Seifert H, Gerke H, Seitz U, Portis M, Soehendra N. Papillary roof incision using the Erlangen-type precut papillatome to achieve selective bile duct cannulation. Gastrointest Endosc 1996; 44:689-95. [AN 97133664]
19. Bruin Slot W, Schoeman MN, DiSario JA, Wolters F, Tytgat GNJ, Huibregtse K. Needle-knife sphincterotomy as a precut procedure: a retrospective evaluation of efficacy and complications. Endoscopy 1996; 28:334-9. [AN 96408491]
20. Sherman S, Lehman GA. Endoscopic pancreatic sphincterotomy: techniques and complications. Gastrointest Endosc Clin N Am 1998; 8:115-24. [AN 98070871]
21. Carr-Locke DL, Conn MI, Faigel DO, Laing K, Leung JW, Mills MR, et al. Technology status evaluation: endosopic pancreatic therapy update. Gastrointest Endosc 1998; 48:723-6. [AN 99069209]
22. Elton E, Howell DA, Parsons WG, Qaseem T, Hanson BL. Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique. Gastrointest Endosc 1998; 47:240-9. [AN 98199944]
23. Patel R, Tarnasky PR, Hennessy WS, Hawes RH, Payne KM, Nelles SE, et al. Does stenting after pancreatic sphincterotomy reduce post-ERCP pancreatitis in patients with prior biliary sphincterotomy?: preliminary results of a prospective randomized trial. Gastrointest Endosc 1999; 49:AB80.
24. Ell C, Rabenstein T, Schneider HT, Ruppert T, Nicklas M, Bulling D. Safety and efficacy of pancreatic sphincterotomy in chronic pancreatitis. Gastrointest Endosc 1998; 48:244-9. [AN 98415847]
25. Desilets DJ, Dy RM, Ku PM, Hanson BL, Elton E, Mattia A, et al. Endoscopic management of tumors of the major duodenal papilla: refined techniques to improve outcome and avoid complications. Gastrointest Endosc 2001; 54:202-8. [AN 21367701]
26. Norton ID, Geller A, Petersen BT, Sorbi D, Gostout CJ. Endoscopic surveillance and ablative therapy for periampullary adenomas. Am J Gastroenterol 2001; 96:101-6. [AN 21039868]
27. Binmoeller KF, Boaventrua S, Ramsperger K, Soehendra N. Endoscopic snare excision of benign adenomas of the papilla of vater. Gastrointest Endosc 1993; 39:127-31. [AN 93266079]
28. Aizawa T, Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc 2002; 54:209-13. [AN 21367702]